Ligand Pharmaceuticals | LGND - 债务利息支出

金融业

USD 311.64

USD 2.24B

现金及等价物

USD 55.96M

USD 12.86M

USD 608.23M

USD 500.57M

USD 1.13B

USD 54.53M

USD 74.27M

68

EPS每股收益

USD 2.67

股本和储备

USD 961.76M

USD 136.18M

债务利息支出

USD 1.79M

USD 7.3M

USD 1.13B

USD 5.42B

USD -28.49M

USD 94.5M

USD 54.53M

普通股股本

USD 19.66M

68.1

USD 64.3M

USD 78.75M

销售和管理费用

USD 72.62M

USD 14.51M

贸易债权人

USD 4.1M

应收帐款人

USD 69.92M

	债务利息支出	更改		日
Agenus	USD 14.67M		1.35M	2026-03
Amgen	USD 653M		94.99B	2026-09
Anika Therapeutics	183.47M		4.09M	2026-06
Arrowhead Research	USD 24.56M		716K	2026-06
Baxter International	USD 64M		14M	2026-06
Bristol-Myers Squibb	USD 403M		4M	2026-09
Eli Lilly	USD 316M		201.3M	2026-09
Enanta Pharmaceuticals	USD 1.96M		620K	2024-12
Enviri Corporation	USD 28.44M		1.74M	2025-12
Gilead Sciences	USD 269M		22M	2026-09
GlaxoSmithKline	GBP 219M		98M	2026-09
Glaxosmithkline	GBP 264.74M		72.01M	2026-09
Heron Therapeutics	USD 600K		100K	2024-12
Insmed	USD 20.41M		1.57M	2026-09
Intrexon	USD 2K		5K	2024-06
Ionis Pharmaceuticals	USD 18M		1000K	2026-06
Karyopharm Therapeutics	USD 12.55M		66K	2026-03
Ligand Pharmaceuticals	USD 1.78M		875K	2025-12
MacroGenics	USD 4.4M		493K	2026-06
Merck	USD 525M		46M	2026-06
Pacira	USD 112.4M		108.78M	2026-09
Pfizer	USD 662M		5M	2026-09
Rigel Pharmaceuticals	USD 2.06M		31K	2024-09
Sangamo BioSciences	97.56M		11.39M	2025-06
Veracyte	USD 2K		1000	2023-12